【発明の名称】二官能性キレート剤としての置換チオ尿素

Title:

【発明の名称】二官能性キレート剤としての置換チオ尿素

Document Type and Number:

Japanese Patent JPH08502240

Kind Code:

A

Abstract:

PCT No. PCT/US93/03208 Sec. 371 Date Jun. 27, 1994 Sec. 102(e) Date Jun. 27, 1994 PCT Filed Apr. 8, 1993 PCT Pub. No. WO93/21151 PCT Pub. Date Oct. 28, 1993This invention relates to chelating agents useful for coupling metal ions to biologically active molecules. In particular, substantial thioureas for chelating metals such as technetium are provided that can be conjugated to a targeting molecule such as an antibody, a peptide or a protein.

More Like This:

WO/2006/060878	METHODS AND COMPOSITIONS FOR ADOPTIVE IMMUNOTHERAPY
JPS63503457	[Title of the Invention] D-GL zygote treatment
JP4965447	Delivery of functional nucleic acids to mammalian cells via bacterial-derived intact minicells

Inventors:

Kagulin, Daniel J.
Berinka, Jr., Benjamin A.

Application Number:

JP51842393A

Publication Date:

March 12, 1996

Filing Date:

April 08, 1993

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Cytogen Corporation

International Classes:

A61K39/44; A61K47/48; A61K51/00; A61K51/08; A61K51/10; C07C335/06; C07C335/14; C07C335/16; C07C335/22; G01N33/58; C07C337/06; C07D207/452; C07D213/34; C07D213/71; C09K3/00; C07D207/44; (IPC1-7): C07C335/06; A61K51/00; C07C335/14; C07C335/16; C07D207/452; C07D213/34; C09K3/00

Attorney, Agent or Firm:

Miyuki Ariga (3 outside)

Previous Patent: アルキルウレア類およびヒドロキシウレアの避妊薬としての使用

Next Patent: 上皮増殖因子受容体およびｅｒｂＢ−２受容体のリガンド増殖因子と相互�...